Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
18
NMPA:18
Drug Approvals
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字HC20250004
- Approval Date
- Mar 25, 2025
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字HC20250003
- Approval Date
- Mar 25, 2025
NMPA
Ritodrine Hydrochloride Tablets
- Product Name
- 安宝
- Approval Number
- 国药准字HC20160013
- Approval Date
- May 31, 2024
NMPA
Montelukast Sodium Tablets
- Product Name
- 孟鲁司特钠片
- Approval Number
- 国药准字HC20240003
- Approval Date
- Jan 23, 2024
NMPA
Glucosamine Sulfate Capsules
- Product Name
- 硫酸氨基葡萄糖胶囊
- Approval Number
- 国药准字HC20120037
- Approval Date
- Aug 29, 2023
NMPA
Glucosamine Sulfate Capsules
- Product Name
- 硫酸氨基葡萄糖胶囊
- Approval Number
- 国药准字HC20120038
- Approval Date
- Aug 29, 2023
NMPA
Glucosamine Sulfate Capsules
- Product Name
- 硫酸氨基葡萄糖胶囊
- Approval Number
- 国药准字HC20120036
- Approval Date
- Aug 29, 2023
NMPA
Sodium Valproate Sustained-release Tablets（Ⅰ）
- Product Name
- 丙戊酸钠缓释片(Ⅰ)
- Approval Number
- 国药准字HC20191001
- Approval Date
- Apr 25, 2023
NMPA
Sodium Valproate Sustained-release Tablets（Ⅰ）
- Product Name
- 丙戊酸钠缓释片(Ⅰ)
- Approval Number
- 国药准字HC20181023
- Approval Date
- Apr 25, 2023
NMPA
Imipenem and Cilastatin Sodium for Injection
- Product Name
- 注射用亚胺培南西司他丁钠
- Approval Number
- 国药准字HC20181017
- Approval Date
- May 13, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found